FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cytarabine Injection
Status: Discontinuation
»Therapeutic Categories: Oncology; Pediatric

Expand all

Mylan Institutional, a Viatris company (New 05/21/2021)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
2 g/20 mL (100 mg/mL), vial (NDC 67457-452-20) 05/21/2021
100 mg/5 mL (20 mg/mL), vial (NDC 67457-455-52) 05/21/2021
1000 mg/50 mL (20 mg/mL), vial (NDC 67457-454-50) 05/21/2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English